No safety concerns so far in Sangamo’s groundbreaking gene-editing trial – pharmaphorum
pharmaphorum |
No safety concerns so far in Sangamo's groundbreaking gene-editing trial
pharmaphorum The trial of Sangamo's gene-editing treatment for a rare and debilitating disease has got off to a good start, with no safety concerns reported so far. The groundbreaking trial hit the headlines around the world in November when Brian Madeux … |
